KEIFERX
KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses. Founded in 2019 and is based in McLean, Virginia.
KEIFERX
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2019-01-01
Address:
Mclean, Virginia, United States
Country:
United States
Website Url:
http://www.keiferx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.keiferx.com Semrush global rank: 4.94 M Semrush visits lastest month: 1.74 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "KeifeRx"
About - KeifeRx
Our leadership team has diverse professional experience across the biopharma ecosystem including an established track record in brain function discovery and multiple neurological drug …See details»
KeifeRx - Crunchbase Company Profile & Funding
Organization. KeifeRx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... KeifeRx is a biotech company focused on the …See details»
KeifeRx Company Profile | Management and Employees List
[email protected]: KeifeRx Top Competitors. Company Employees Revenue Top technologies; Neuropore Therapies Inc. 16: $4.1 M: Cogentis Therapeutics Inc. 8: $519 K: Cognition …See details»
Media - KeifeRx
KeifeRx has a full range of neuroscience (NS) drug candidates in development, spanning later-stage clinical assets to several novel, pre-IND technologies View Article Jul 5, 2023See details»
KeifeRx Company Profile 2024: Valuation, Funding & Investors
KeifeRx General Information Description. Operator of a life sciences company intended to develop novel treatments for neurodegenerative diseases. The company focuses on the development …See details»
KeifeRx - Funding, Financials, Valuation & Investors - Crunchbase
KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses. Search Crunchbase ... Products. Resources. Pricing. Resources. …See details»
KeifeRx LLC - Pitch
Feb 14, 2019 KeifeRx is building upon its extensive clinical experience at Georgetown University in neurodegenerative diseases to advance a second generation of orally delivered small …See details»
KeifeRx - Contacts, Employees, Board Members, Advisors & Alumni
KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.See details»
KeifeRx LLC - Drug pipelines, Patents, Clinical trials - Synapse
Explore KeifeRx LLC with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 8 news, Disease Domain:Nervous System Diseases, Endocrinology and Metabolic Disease, …See details»
KeifeRx - Company Profile - Tracxn
Dec 6, 2024 KeifeRx - Developer of novel therapies for the treatment of neurodegenerative diseases. Raised a total funding of $6M over 1 round. Founded by Charbel Moussa and …See details»
KEIFERX LLC Company Profile | McLean, VA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for KEIFERX LLC of McLean, VA. Get the latest business insights from Dun & Bradstreet.See details»
KeifeRx - Work in biotech
KeifeRx is focused on developing innovative therapies for neurodegenerative and immune diseases. Their research centers around the role of autophagy in the progression of these …See details»
KeifeRx | VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
KeifeRx - Tech Stack, Apps, Patents & Trademarks - Crunchbase
KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.See details»
KeifeRx - Products, Competitors, Financials, Employees, …
KeifeRx Announces the Appointments of Dan Feehan and Alison Finger to Board of Directors. Mar 27, 2024. New Board Members Add Operational and Product Development Expertise as …See details»
KeifeRx - Overview, News & Similar companies | ZoomInfo.com
Feb 13, 2023 KeifeRx to Present at BIO International Convention 2022 WASHINGTON, June 2, 2022 /PRNewswire/ -- KeifeRx, an emerging clinical-stage biopharmaceutical company …See details»
Science - KeifeRx
KeifeRx’s selective kinase inhibitors also act on the immune system via mast cells, which play an essential role in the innate immune response at sites of injury. In the brain, mast cells play a …See details»
KFRX-03 - Drug Targets, Indications, Patents - Synapse - Patsnap
About KeifeRx KeifeRx is an emerging clinical-stage biopharmaceutical company developing a portfolio of novel and optimized, low-dose, orally-delivered kinase inhibitors for the treatment …See details»
Pipeline - KeifeRx
KeifeRx is building upon its extensive clinical experience in neurodegenerative diseases to advance a second generation of orally delivered small molecules that demonstrate high blood …See details»